港股異動丨丘鈦科技漲8.61% 去年純利升2.7%至8.63億元 營收穩健增長
格隆匯3月24日丨丘鈦科技(01478.HK)漲8.61%,報6.56港元,總市值78億港元。丘鈦科技本週一公佈2021年度業績,期內集團實現營業收入186.63億元,同比增長7.3%;毛利17.62億元,同比下降0.5%,毛利率由上年同期的10.2%降至9.4%;公司股權持有人應占溢利8.63億元,同比增長2.7%;每股基本盈利73.2分,不派末期股息。營業收入穩健增長主要得益於攝像頭模組銷售數量同比增長約22.1%;利潤提升主要得益於攝像頭模組銷售數量的穩健增長帶動集團營業收入實現同比穩健增長。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.